Internal Medicine, Cardiovascular Disease · Sebring, FL
NPI
1528049483
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2227 US Highway 27 S Unit 101
Sebring, FL, 33870
Phone (863) 385-4300
Groups this clinician bills Medicare through
Medicare paid, 2024
$550K
9,563 services
Medicare patients, 2024
1,882
Average age 78
Drug cost, 2024
$2.3M
9,251 prescriptions
Company payments, 2025
$1,429
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel T Parnassa was code 99214 (office e&m - established), 2,382 times for 1,378 patients. In total Daniel T Parnassa billed 9,563 services in 50 codes, and Medicare paid $550K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,382 | 1,378 | $88.88 | $212K |
| 93000 Electrocardiogram | Office | 2,098 | 1,502 | $9.81 | $21K |
| 93306 Echocardiography (TTE/TEE) | Office | 490 | 470 | $141.75 | $69K |
| 93298 External Electrocardiographic Monitoring | Office | 490 | 89 | $69.54 | $34K |
| 93296 External Electrocardiographic Monitoring | Office | 398 | 188 | $14.04 | $5,587 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 387 | 387 | $134.21 | $52K |
| 93793 Care Management/Coordination | Office | 361 | 50 | $8.26 | $2,982 |
| 93306 Echocardiography (TTE/TEE) | Facility | 357 | 339 | $51.36 | $18K |
| 93294 External Electrocardiographic Monitoring | Office | 335 | 157 | $20.08 | $6,728 |
| 99204 Office E&M - New | Office | 296 | 296 | $119.06 | $35K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 228 | 57 | $2.48 | $566 |
| 93288 External Electrocardiographic Monitoring | Office | 211 | 144 | $13.59 | $2,868 |
| 99213 Office E&M - Established | Office | 186 | 176 | $55.53 | $10K |
| 93280 External Electrocardiographic Monitoring | Office | 151 | 113 | $24.28 | $3,666 |
| 99222 Hospital E&M - Initial | Facility | 142 | 133 | $100.79 | $14K |
By year: 2022 $589K for 10,066 services; 2023 $495K for 9,281 services; 2024 $550K for 9,563 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 77 | 38 | $4.20 | $323 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel T Parnassa prescribed most often to Medicare patients was Eliquis (Apixaban), with 917 prescriptions and refills. In total Daniel T Parnassa wrote 9,251 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 917 | 1,911 | 256 | $1.1M |
| Metoprolol Tartrate Generic | 508 | 1,236 | 235 | $2,779 |
| Metoprolol Succinate Generic | 504 | 1,399 | 177 | $6,694 |
| Atorvastatin Calcium Generic | 500 | 1,451 | 173 | $4,828 |
| Clopidogrel Clopidogrel Bisulfate | 455 | 1,312 | 169 | $4,846 |
| Carvedilol Generic | 426 | 1,165 | 146 | $3,741 |
| Losartan Potassium Generic | 411 | 1,176 | 140 | $4,215 |
| Diltiazem Hcl Generic | 309 | 810 | 112 | $7,783 |
| Amlodipine Besylate Generic | 302 | 878 | 115 | $1,972 |
| Ranolazine Er Ranolazine | 273 | 685 | 101 | $28K |
| Nitroglycerin Generic | 237 | 275 | 156 | $2,820 |
| Xarelto Rivaroxaban | 233 | 503 | 69 | $277K |
| Lisinopril Generic | 219 | 621 | 75 | $1,504 |
| Entresto Sacubitril/Valsartan | 208 | 369 | 62 | $227K |
| Repatha Sureclick Evolocumab | 207 | 361 | 44 | $206K |
Brand drugs: 2,157 claims; generic drugs: 7,094 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel T Parnassa $1,429 ($1,429 in general payments such as food, travel and fees) from 17 companies. The largest payer was Pfizer Inc. with $279.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 16 | $279 |
| Merck Sharp & Dohme LLC MRK | 6 | $142 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $142 |
| Esperion Therapeutics, Inc. ESPR | 7 | $135 |
| Alnylam Pharmaceuticals Inc. ALNY | 4 | $99.52 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $96.8 |
| Philips North America LLC PHG | 5 | $95.93 |
| Amgen Inc. AMGN | 6 | $87.14 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $74.19 |
| Heartflow, Inc. HTFL | 2 | $59.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.